UNSPSC 85891826: High dose rate (hdr) brachytherapy of pituitary gland using californium 252 (cf-252)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of pituitary gland using californium 252 (cf-252). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DG109CZ

UNSPSC 85891826 High dose rate brachytherapy of pituitary gland using californium 252 (Commodity) shows no relevant recent state and local procurement activity. The single opportunity tagged under this code—Santa Clara County Health System's RFQ for temporary health professional staffing services (RFSQHHSFY270052, due October 7, 2026)—is plainly unrelated to the code's stated scope of specialized radiation oncology treatment. The solicitation covers ancillary clinical staffing across audiology, cardiology, diagnostic imaging, gastroenterology, and related disciplines, not brachytherapy or any radiological treatment delivery. This mismatch indicates either a data-entry error in the opportunity record or a miscoding in the UNSPSC taxonomy application, rendering the code unreliable for identifying actual state and local demand for high dose rate brachytherapy services at this time.

The code appears inactive in state and local procurement as currently indexed. Business development professionals should verify whether opportunities in medical physics, radiation oncology treatment planning, or specialized clinical equipment procurement may be tagged under different UNSPSC codes, or monitor this code for future activity once classification errors are corrected.